Personalizing Therapy for Patients With CML

Michael J. Mauro, MD

Video Categories: CML

Dr. Mauro addresses the debate over selecting first line therapy with three approved agents available.
January 30, 2014

Benefits of Congresses and Journals in Educating on Personalized Medicine

Dr Agarwala provides his perspective on the importance of the Global Biomarkers Consortium, World Cutaneous Malignancies Congress and the journal Personalized Medicine in Oncology.

September 7, 2018

Why Are Clinical Trials Important?

Dr Andrey Antov believes it’s important for patients to participate in clinical trials for a multitude of reasons, as clinical trials can benefit both the patient and the healthcare system as a whole.